Crocodile Capital Partners Gmb H Bio N Tech Se Transaction History
Crocodile Capital Partners Gmb H
- $62.8 Billion
- Q2 2024
A detailed history of Crocodile Capital Partners Gmb H transactions in Bio N Tech Se stock. As of the latest transaction made, Crocodile Capital Partners Gmb H holds 29,586 shares of BNTX stock, worth $3.32 Million. This represents 3.78% of its overall portfolio holdings.
Number of Shares
29,586
Previous 29,586
-0.0%
Holding current value
$3.32 Million
Previous $2.73 Billion
12.89%
% of portfolio
3.78%
Previous 3.76%
Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$929 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$538 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$492 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$329 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$213 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.2B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...